Abiopharma

🔍 KAMERICK EILEEN A (Director)

Company: ASSOCIATED BANC-CORP (ASB)

Report Date: 2026-03-16

Detailed Transactions and Holdings:

• Acquired 44 shares of Common Stock $0.01 Par Value at $24.59 per share (Direct)
  Date: 2026-03-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 49,308.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 417 shares of Common Stock $0.01 Par Value at $24.59 per share (Direct)
  Date: 2026-03-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 49,725.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Dividend equivalent units, which vest on the first anniversary of the grant of the restricted stock units to which they relate, are payable solely in shares of common stock upon vesting (subject to deferral if so elected by the Insider).
• F2: Fully vested dividend equivalents received on restricted stock units payable solely in shares of common stock following the date the Insider ceases serving as a director.